He has over 35 years’ experience and is currently spearheading the turnaround at AIM-listed e-Therapeutics, where he is also chairman.
Ross has boardroom roles at Biomer Technology, Premier Veterinary Group and ASX-quoted Anatara Lifesciences as well as being a director of Aldershot Town Football Club.
Previous appointments included the chairmanship of Silence Therapeutics, chief executive of Allergy Therapeutics and CEO of Quadrant Healthcare.
Welcoming the new chairman on board, RedX boss Neil Murray said: “His extensive experience in the life science sector makes him the ideal candidate to take on this role.
“I am confident that under his stewardship the company will deliver shareholder value as we transition into a clinical-stage research and development company with a focus on cancer, immunology and infection."